Role of Defensins in Tumor Biology
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065268 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lowie Adyns und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 …. Hauptthemen laut MEDLINE: beta-Defensins, alpha-Defensins. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation - Flanders, KU Leuven, C1 funding.
Abstract (Originalsprache)
Defensins have long been considered as merely antimicrobial peptides. Throughout the years, more immune-related functions have been discovered for both the α-defensin and β-defensin subfamily. This review provides insights into the role of defensins in tumor immunity. Since defensins are present and differentially expressed in certain cancer types, researchers started to unravel their role in the tumor microenvironment. The human neutrophil peptides have been demonstrated to be directly oncolytic by permealizing the cell membrane. Further, defensins can inflict DNA damage and induce apoptosis of tumor cells. In the tumor microenvironment, defensins can act as chemoattractants for subsets of immune cells, such as T cells, immature dendritic cells, monocytes and mast cells. Additionally, by activating the targeted leukocytes, defensins generate pro-inflammatory signals. Moreover, immuno-adjuvant effects have been reported in a variety of models. Therefore, the action of defensins reaches beyond their direct antimicrobial effect, i.e., the lysis of microbes invading the mucosal surfaces. By causing an increase in pro-inflammatory signaling events, cell lysis (generating antigens) and attraction and activation of antigen presenting cells, defensins could have a relevant role in activating the adaptive immune system and generating anti-tumor immunity, and could thus contribute to the success of immune therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
- Centre for Proteomics, University of Antwerp, 2020 Antwerpen, Belgium.
- Health Unit, VITO, 2400 Mol, Belgium.
ORCID-Profile: Lowie Adyns, Paul Proost, Sofie Struyf
Förderung
- Research Foundation - Flanders
- KU Leuven
- C1 funding
- a SB PhD fellowship of FWO-Vlaanderen
Zitieren
APA
Adyns, L., Proost, P., & Struyf, S. (2023). Role of Defensins in Tumor Biology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065268
Vancouver
Adyns L, Proost P, Struyf S. Role of Defensins in Tumor Biology. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065268
BibTeX
@article{Adyns2023,
author = {Adyns, Lowie and Proost, Paul and Struyf, Sofie},
title = {Role of Defensins in Tumor Biology},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065268}
}
EUVIMED